MedTrace Logo

Music Therapy for Pain Modification in Pediatric Palliative Care

NCT01456884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2017-09-11

No results posted yet for this study

Summary

The purpose of this within-subjects randomized controlled trial is to determine whether two music therapy interventions are efficacious in reducing pain symptoms, in order to improve the quality of care for children in pediatric hospice. The investigators hypothesize that both music therapy interventions, live guitar and vocal intervention and vibroacoustic intervention, will reduce behavioural pain scores and that behavioural pain scores will correlate with physiological outcome measures.

Conditions

  • Neurological Impairment

Interventions

BEHAVIORAL

Live guitar and vocal music therapy

Live guitar and vocal music therapy. Subject is passive recipient for 30 minutes.

BEHAVIORAL

Vibroacoustic Music Therapy

30 minutes using vibroacoustic mat.

Sponsors & Collaborators

  • American Music Therapy Association

    collaborator OTHER

  • Canuck Place Children's Hospice

    collaborator UNKNOWN

  • Child and Family Research Institute

    collaborator OTHER

  • BC Women's Hospital and Health Centre

    collaborator UNKNOWN

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Liisa Holsti, PhD · University of British Columbia

  • Beth Clark, MM · Canuck Place Children's Hospice

  • Harold Siden, MD · Canuck Place Children's Hospice

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
12 Months
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01456884 on ClinicalTrials.gov